A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Have persistent post cataract extraction macular edema whose condition is stable
Have no change in medication regimen of immunosuppressive or anti-inflammatory agents; steroidal or non-steroidal agents for a specified period of time prior to randomization
Have at least one eligible eye to be treated in the study
Have an optical coherence tomography (OCT) scan with a qualifying retinal thickness in the study eye
Have macular edema confirmed by fluorescein angiography
Have proliferative vitreoretinopathy greater than grade B in either eye
Have ocular disorders in the study eye that may confound interpretation of study results
Have ophthalmic disorders in the study eye that may influence final visual acuity and/or fluorescein angiography interpretation
Have had cataract surgery in the study eye in the past 2 months, YAG laser capsulotomy within the past 1 month, or any other intraocular surgery within the past 90 days
Have uncontrollable elevated intraocular pressure (IOP) or advanced glaucoma
Have had any periocular or intravitreal injection of corticosteroids in the study eye within 3 months
Have had any ocular implant device for the delivery of therapeutic agents
Be taking any excluded medications that could obscure or confound study results